Standard Investment, together with the company's management team, have acquired DSM Synres from Royal DSM. Financial details have not been disclosed.
DSM Synres, which now continues its operations under the name Synres B.V., is a manufacturer and supplier of solvent-borne alkyd and acrylic coating resins for the coating, adhesives and graphic arts market on a global scale. The company has been active over 65 years and its products are used in the decorative, industrial metal and marine industries.
Standard Investment is a Dutch-based private equity firm with a hands-on approach. The firm invests in small to medium-sized enterprises in Belgium and the Netherlands.
Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in life sciences and materials sciences, DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders simultaneously. The company delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials.
Oaklins' debt advisory team in the Netherlands advised the management team of DSM Synres during the entire sale process. The advice included, among others, sensitivity analysis of proposed management packages including both financial and other commercial terms.
Daniël Brabander, Finance Director of Royal DSM, commented: “The team's support stretched beyond financial modeling by assisting the participants in strategic positioning throughout the entire process.”
© Oaklins. All rights reserved. Oaklins refers to Oaklins International Inc. and/or one of its member firms, each of which is a separate legal entity. Please see www.oaklins.com/legal for further details.